Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?Cancer communications (London, England), 2019-04, Vol.39 (1), p.1-12 [Peer Reviewed Journal]The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0368-6 ;PMID: 31030667Full text available |
|
2 |
Material Type: Article
|
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancerCancer communications (London, England), 2019-03, Vol.39 (1), p.1-31 [Peer Reviewed Journal]The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0349-9 ;PMID: 30885279Full text available |
|
3 |
Material Type: Article
|
The immune landscape of esophageal cancerCancer communications (London, England), 2019-11, Vol.39 (1), p.79-79, Article 79 [Peer Reviewed Journal]2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0427-z ;PMID: 31771653Full text available |
|
4 |
Material Type: Article
|
Mucinous colorectal adenocarcinoma: clinical pathology and treatment optionsCancer communications (London, England), 2019-03, Vol.39 (1), p.1-13 [Peer Reviewed Journal]The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0361-0 ;PMID: 30922401Full text available |
|
5 |
Material Type: Article
|
National trend of gastric cancer mortality in China (2003–2015): a population‐based studyCancer communications (London, England), 2019-05, Vol.39 (1), p.1-5 [Peer Reviewed Journal]The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0372-x ;PMID: 31046840Full text available |
|
6 |
Material Type: Article
|
Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancerCancer communications (London, England), 2019-11, Vol.39 (1), p.76-76, Article 76 [Peer Reviewed Journal]2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0425-1 ;PMID: 31753020Full text available |
|
7 |
Material Type: Article
|
Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectivesCancer communications (London, England), 2019-07, Vol.39 (1), p.1-11 [Peer Reviewed Journal]The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0387-3 ;PMID: 31307548Full text available |
|
8 |
Material Type: Article
|
Cancer cell reprogramming: a promising therapy converting malignancy to benignityCancer communications (London, England), 2019-08, Vol.39 (1), p.1-13 [Peer Reviewed Journal]The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0393-5 ;PMID: 31464654Full text available |
|
9 |
Material Type: Article
|
PD‐L1 and PD‐L2 expression correlated genes in non‐small‐cell lung cancerCancer communications (London, England), 2019-06, Vol.39 (1), p.1-14 [Peer Reviewed Journal]The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0376-6 ;PMID: 31159869Full text available |
|
10 |
Material Type: Article
|
China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non‐small cell lung cancer after two lines of chemotherapyCancer communications (London, England), 2019-06, Vol.39 (1), p.1-10 [Peer Reviewed Journal]The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0383-7 ;PMID: 31221221Full text available |
|
11 |
Material Type: Article
|
Regulation of CD137 expression through K‐Ras signaling in pancreatic cancer cellsCancer communications (London, England), 2019-07, Vol.39 (1), p.1-11 [Peer Reviewed Journal]The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0386-4 ;PMID: 31288851Full text available |
|
12 |
Material Type: Article
|
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first‐line chemotherapy of HER2‐negative metastatic breast cancerCancer communications (London, England), 2019-01, Vol.39 (1), p.1-10 [Peer Reviewed Journal]The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-018-0346-4 ;PMID: 30606259Full text available |
|
13 |
Material Type: Article
|
Towards precision medicine: advances in 5‐hydroxymethylcytosine cancer biomarker discovery in liquid biopsyCancer communications (London, England), 2019-03, Vol.39 (1), p.1-9 [Peer Reviewed Journal]The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0356-x ;PMID: 30922396Full text available |
|
14 |
Material Type: Article
|
Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancerCancer communications (London, England), 2019-04, Vol.39 (1), p.1-9 [Peer Reviewed Journal]The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0365-9 ;PMID: 30999966Full text available |
|
15 |
Material Type: Article
|
Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cellsCancer communications (London, England), 2019-06, Vol.39 (1), p.1-16 [Peer Reviewed Journal]The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0379-3 ;PMID: 31200766Full text available |
|
16 |
Material Type: Article
|
Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axisCancer communications (London, England), 2019-12, Vol.39 (1), p.81-81, Article 81 [Peer Reviewed Journal]2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0424-2 ;PMID: 31796105Full text available |
|
17 |
Material Type: Article
|
Expression and clinical value of programmed cell death-ligand 1 (PD-L1)in diffuse large B cell lymphoma: a retrospective studyAi zheng, 2017-12, Vol.36 (12), p.767-777, Article 94 [Peer Reviewed Journal]2017 The Author(s) ;COPYRIGHT 2017 John Wiley & Sons, Inc. ;2017. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © Wanfang Data Co. Ltd. All Rights Reserved. ;The Author(s) 2017 ;ISSN: 1000-467X ;ISSN: 2523-3548 ;ISSN: 1944-446X ;EISSN: 1944-446X ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-017-0262-z ;PMID: 29246182Full text available |
|
18 |
Material Type: Article
|
Dual prognostic role of 2‐oxoglutarate‐dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenanceCancer communications (London, England), 2019-04, Vol.39 (1), p.1-14 [Peer Reviewed Journal]The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0369-5 ;PMID: 31036064Full text available |
|
19 |
Material Type: Article
|
A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomyCancer communications (London, England), 2019-10, Vol.39 (1), p.1-11 [Peer Reviewed Journal]The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0404-6 ;PMID: 31601270Full text available |
|
20 |
Material Type: Article
|
Identification of genetic alterations associated with primary resistance to EGFR‐TKIs in advanced non‐small‐cell lung cancer patients with EGFR sensitive mutationsCancer communications (London, England), 2019-03, Vol.39 (1), p.1-15 [Peer Reviewed Journal]The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0354-z ;PMID: 30823937Full text available |